Paper41535685
Protection of multiple aspects of Alzheimer's disease pathology using dietary supplementation with taurine.
Tognoni CM and 5 others. Sci Rep, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Protection of multiple aspects of Alzheimer's disease pathology using dietary supplementation with taurine. Papers, record 41535685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41535685
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protection of multiple aspects of Alzheimer's disease pathology using dietary supplementation with taurine.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Taurine | Major topic |
| Alzheimer Disease | Major topic |
| Dietary Supplements | Major topic |
| Neuroprotective Agents | Major topic |
| Animals | |
| Mice | |
| Disease Models, Animal | |
| Magnetic Resonance Spectroscopy | |
| Mice, Transgenic | |
| Amyloid beta-Peptides | |
| Male | |
| Cytokines |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG069228 | NIA NIH HHS | United States | R01AG069228 | PubMed | NIH RePORTER |
| MFE-194064 | CIHR | Canada | PubMed | PubMed | |
| RF1 AG069228 | NIA NIH HHS | United States | RF1AG069228 | PubMed | NIH RePORTER |
| 1RF1AG069228 ; 5R01AG070257 | NIH HHS | United States | RF1AG069228 | PubMed | NIH RePORTER |
| R01 AG070257 | NIA NIH HHS | United States | R01AG070257 | PubMed | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 41282082 | Protection of multiple aspects of Alzheimer's disease pathology using dietary supplementation with taurine. | https://conductscience.org/library/papers/41282082 |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33727609 | Electronegative very-low-density lipoprotein induces brain inflammation and cognitive dysfunction in mice. | Sci Rep | 2021 | https://conductscience.org/library/papers/33727609 | PubMed |
| 2 | 36902391 | Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902391 | PubMed |
| 3 | 29273078 | Practical considerations for choosing a mouse model of Alzheimer's disease. | Mol Neurodegener | 2017 | https://conductscience.org/library/papers/29273078 | PubMed |
| 4 | 2089275 | Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. | Neuroscience | 1990 | https://conductscience.org/library/papers/2089275 | PubMed |
| 5 | 31358793 | Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer's disease. | Sci Rep | 2019 | https://conductscience.org/library/papers/31358793 | PubMed |
| 6 | 12552120 | Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12552120 | PubMed |
| 7 | 23327111 | Protective effects of taurine against closed head injury in rats. | J Neurotrauma | 2015 | https://conductscience.org/library/papers/23327111 | PubMed |
| 8 | 28703214 | Stop Alzheimer's before it starts. | Nature | 2017 | https://conductscience.org/library/papers/28703214 | PubMed |
| 9 | 23040664 | CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease. | Neurobiol Aging | 2013 | https://conductscience.org/library/papers/23040664 | PubMed |
| 10 | 7892497 | Probable Alzheimer disease: diagnosis with proton MR spectroscopy. | Radiology | 1995 | https://conductscience.org/library/papers/7892497 | PubMed |
| 11 | 17046788 | Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity. | J Mol Biol | 2006 | https://conductscience.org/library/papers/17046788 | PubMed |
| 12 | 21825241 | The dynamics of cortical and hippocampal atrophy in Alzheimer disease. | Arch Neurol | 2011 | https://conductscience.org/library/papers/21825241 | PubMed |
| 13 | 15003996 | Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. | FASEB J | 2004 | https://conductscience.org/library/papers/15003996 | PubMed |
| 14 | 37153279 | Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review. | Cureus | 2023 | https://conductscience.org/library/papers/37153279 | PubMed |
| 15 | 22840748 | scyllo-Inositol, preclinical, and clinical data for Alzheimer's disease. | Adv Pharmacol | 2012 | https://conductscience.org/library/papers/22840748 | PubMed |
| 16 | 33778150 | Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease. | Alzheimers Dement (N Y) | 2021 | https://conductscience.org/library/papers/33778150 | PubMed |
| 17 | 29775591 | Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration. | Cell | 2018 | https://conductscience.org/library/papers/29775591 | PubMed |
| 18 | 28849459 | Taurine Directly Binds to Oligomeric Amyloid-β and Recovers Cognitive Deficits in Alzheimer Model Mice. | Adv Exp Med Biol | 2017 | https://conductscience.org/library/papers/28849459 | PubMed |
| 19 | 32968166 | Evaluation of the neuroprotective effect of taurine in Alzheimer's disease using functional molecular imaging. | Sci Rep | 2020 | https://conductscience.org/library/papers/32968166 | PubMed |
| 20 | 2150771 | Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients. | Brain Res | 1990 | https://conductscience.org/library/papers/2150771 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41893715 | Canine Cognitive Dysfunction and Alzheimer's Disease: Pathophysiological Relationships and the Impact of Glymphatic System Impairment on Neurodegeneration. | Vet Sci | 2026 | https://conductscience.org/library/papers/41893715 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41535685
GET https://conductscience.org/api/papers/v1/41535685/references?page=2